NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 9, 2014
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Exercise/Conversion
Common Stock
2014-01-07$0.30/sh+70,000$21,000→ 357,304 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-01-07−70,000→ 0 totalExercise: $0.30Exp: 2014-01-07→ Common Stock (70,000 underlying) - Tax Payment
Common Stock
2014-01-07$1.93/sh−34,308$66,214→ 322,996 total
Holdings
- 93,217(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Shares withheld by the issuer in payment of the option exercise price and to satisfy tax withholding obligations.
- [F2]Option vests 1/3 of the underlying shares annually beginning on the first anniversary of the date of grant.